Related references
Note: Only part of the references are listed.Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Impedance measurement for real time detection of neuronal cell death
S. Diemert et al.
JOURNAL OF NEUROSCIENCE METHODS (2012)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo
L. P. Mueller et al.
CANCER GENE THERAPY (2011)
Potential implications of mesenchymal stem cells in cancer therapy
Long-Jun Dai et al.
CANCER LETTERS (2011)
In vitro effects of an in silico-modelled 17β-estradiol derivative in combination with dichloroacetic acid on MCF-7 and MCF-12A cells
X. X. Stander et al.
CELL PROLIFERATION (2011)
HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species
Dan-Ming Zhu et al.
PLOS ONE (2011)
Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
Xu-Yong Sun
World Journal of Stem Cells (2011)
TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors
Dominic Stadel et al.
CLINICAL CANCER RESEARCH (2010)
Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment
Shannon Kidd et al.
CYTOTHERAPY (2010)
Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence
Jana Luetzkendorf et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β
Shyam A. Patel et al.
JOURNAL OF IMMUNOLOGY (2010)
TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
Johannes Lemke et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells
Andrea Mohr et al.
STEM CELLS (2010)
Targeting Tumor Stroma Using Engineered Mesenchymal Stem Cells Reduces the Growth of Pancreatic Carcinoma
Christoph Zischek et al.
ANNALS OF SURGERY (2009)
Magnetic Resonance Imaging of Mesenchymal Stem Cells Homing to Pulmonary Metastases Using Biocompatible Magnetic Nanoparticles
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
DUAL-TARGETED ANTITUMOR EFFECTS AGAINST BRAINSTEM GLIOMA BY INTRAVENOUS DELIVERY OF TUMOR NECROSIS FACTOR-RELATED, APOPTOSIS-INDUCING, LIGAND-ENGINEERED HUMAN MESENCHYMAL STEM CELLS
Bojie Yang et al.
NEUROSURGERY (2009)
High TRAIL Death Receptor 4 and Decoy Receptor 2 Expression Correlates With Significant Cell Death in Pancreatic Ductal Adenocarcinoma Patients
Ahter Dilsad Sanlioglu et al.
PANCREAS (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
Shannon Kidd et al.
STEM CELLS (2009)
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Ling Qiao et al.
CELL RESEARCH (2008)
A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury
Z-X Zhang et al.
CYTOTHERAPY (2008)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells
Lata G. Menon et al.
STEM CELLS (2007)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Aarif Y. Khakoo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter
D Jacob et al.
CANCER GENE THERAPY (2005)
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2 - Randomized controlled trial evaluating survival, morbidity, and mortality
CJ Yeo et al.
ANNALS OF SURGERY (2002)
Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death
SM Ibrahim et al.
PANCREAS (2001)
Share Paper
